Amy Lin, Technologist, Toronto, CanadaCreating solutions for tomorrow through research and development
Researching and developing medicines to treat diseases are at the cornerstone of what we do.
Collectively, our natural curiosity, our exploration of the unexpected and a patient first attitude allows us to continuously chase the miracles of science.
Sushrut Nambiat, Technologist, Toronto, CanadaInvestment Leader
As one of the top three R&D spenders within the Canadian pharmaceutical and biotechnology industries, and consistently a top spender as a percentage of revenue, we are focused on developing innovative therapies in areas such as oncology, diabetes and cardiology.
L-R Francisca Aidoo-Nyarko, Technologist, and Ju Huang, Senior Scientist, Toronto, CanadaR&D Centre of Excellence
As the home of Sanofi’s North American Centres of Excellence for Analytical and Bioprocess R&D, our Toronto site plays an active role in developing new vaccines. Close to 300 people work in R&D at our Toronto site, including dozens of PhDs, Doctors of Pharmacy and bioprocess engineers with extensive academic and/or industry experience.
2024 winners of the Sanofi Canada Biogenius CompetitionBiogenius Competition
While simple science activities tap into our desire to explore and experiment, the Sanofi Biogenius Canada Competition takes its up a few notches. And rightly so.
The Sanofi Biogenius Canada Competition encourages high school students from coast-to-coast-to-coast to be curious and explore real-life science, technology, engineering, and mathematics (STEM) research ideas that have the potential change lives.
No ordinary science fair, it annually celebrates outstanding research projects submitted from across the country, from those in Grades 7 to 12, focusing on health sciences, life sciences and biotechnology. Hosted in partnership with Youth Science Canada, the competition is part of their regional and Canada-Wide Science Fair (CWSF).
Three winners are chosen in each of the three divisions: Junior (Grades 7 and 8), Intermediate (Grades 9 and 10) and Senior (Grades 11 and 12).
L-R Sung-In Back, Technologist, and Sahar Esmaeili Samani, Scientist, Vaccine Drug Product Development, Toronto, CanadaClinical Research
Canada has an outstanding reputation for clinical research, built on consistently generating quality data necessary to evaluate a drug’s performance. With over 70 Sanofi-sponsored clinical studies and over 25 investigator-sponsored trials underway in a wide range of therapeutic areas, the Clinical Study Unit in Canada contributes significantly to Sanofi’s global efforts to develop new treatments.
Therapeutic areas of study
- Health and Well-being
- Diabetes and Cardiovascular Diseases
- Oncology
- Immunology
- Multiple Sclerosis
- Rare Diseases
- Rare Blood Disorders
- Vaccines
Al Hassan Casse, Scientist, FrancePatient Support
As a health journey partner, we focus on one objective: improving access to healthcare and high-quality medications.
In addition to providing medications in a wide range of therapeutic areas, Sanofi Canada also offers a number of patient-focused programs designed to help people better manage their health and secure access to the treatments they need.
RxHelp
Where permitted, a free prescription savings card available to all Canadian residents, whether or not they have an existing drug plan
Francisca Aidoo-Nyarko, Technologist, Toronto, CanadaA leader in clinical research in Canada
Canada has an outstanding reputation for clinical research, built on consistently generating quality data necessary to evaluate a drug’s performance. The high level of medical expertise in Canada and the openness of investigative centres to clinical development make Canada attractive for Sanofi’s clinical research operations.
Cooperative projects with many partners
The Clinical Study Unit in Canada contributes significantly to Sanofi’s global efforts to develop new treatments. Our teams are currently overseeing some 80 Sanofi-sponsored clinical studies in a wide range of therapeutic areas, working with clinics and hospitals across the country.
Clinical studies are crucial in determining whether a particular drug is safe and effective, at which dosage, and any potential side effects. Only with all these data can regulatory approval (Health Canada’s “Notice of Compliance”) be obtained and the medicine made available to patients. Once a medicine is on the market, additional studies may be performed to learn more about its effectiveness and safety in various patient groups.
Ongoing clinical activities in Canada
80+
company-sponsored studies currently underway
25+
investigator-sponsored trials currently underway
3,300+
patients taking part from coast to coast
L-R Mathilde Scheuber, Scientist, Francisca Aidoo-Nyarko, Technologist, and Ju Huang, Senior Scientist, Toronto, CanadaInvestigator-Sponsored Studies
Sanofi is committed to supporting medically and scientifically sound research aimed at the advancement of disease knowledge and potential treatments in therapeutic areas of interest to Sanofi with the goal of advancing patient care.